Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
27
28
Next >
Novartis Injects $300M In Early-Stage Biologics Research Tech
September 12, 2022
Tickers
NVS
Tags
General
Biotech
Briefs
From
Benzinga
Novartis' Kisqali Adds One More Year Of Survival Benefit In Breast Cancer Setting
September 09, 2022
Tickers
NVS
Tags
Biotech
Benzinga
Large Cap
From
Benzinga
No Early Relief for JW Therapeutics from Cancer Wonder Drug
September 07, 2022
Tickers
ASIA
LEGN
NVS
Tags
LEGN
Benzinga
Markets
From
Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
September 01, 2022
Tickers
AMD
AMZN
BA
BABA
Tags
AMD
XOM
Media
From
Benzinga
Novartis Appoints Merck Executive As Research Head
September 01, 2022
Tickers
GSK
MRK
NVS
Tags
News
Large Cap
Management
From
Benzinga
Novartis' Scemblix Snags European Approval For Chronic Myeloid Leukemia
August 29, 2022
Tickers
NVS
PFE
Tags
Benzinga
Biotech
PFE
From
Benzinga
U.S.-China relations just got a whole lot better, boosting the prospects of these three stocks
August 28, 2022
Tickers
AMGN
BABA
BGNE
BMY
Tags
AMGN
CHNA
PRWAX
From
MarketWatch
With Sandoz Spinoff, Novartis Slams Brakes On Huntington's Trial
August 25, 2022
Tickers
NVS
Tags
News
Large Cap
Health Care
From
Benzinga
Benzinga Before The Bell: Twitter Whistleblower Peiter Zatko To Depose Before Senate Panel, GameStop To Boost Employee Compensation To Drive Growth, California Proposes Total Ban On New Gasoline Car S
August 25, 2022
Tickers
AMZN
BIDU
GME
HMC
Tags
Benzinga
BIDU
PINS
From
Benzinga
Fed heroics or no, the S&P 500 level is destined for a retest of lows. These are the levels to watch, says this strategist
August 25, 2022
Tickers
AAPL
AMC
AMZN
APE
Tags
TACK
DG
GME
From
MarketWatch
Novartis To Spinoff Sandoz Business To Create #1 European Generics Company
August 25, 2022
Tickers
NVS
Tags
General
Benzinga
Biotech
From
Benzinga
Novartis to spin off, list Sandoz business
August 25, 2022
Tickers
NVS
Tags
NVS
CH:NOVN
From
MarketWatch
Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
August 18, 2022
Tickers
CRBU
GILD
NVS
Tags
CRBU
Price Target
Market News
From
Benzinga
A Look Into Healthcare Sector Value Stocks
August 15, 2022
Tickers
BNTX
MRNA
NVS
OGN
Tags
Benzinga
BNTX
TALK
From
Benzinga
Novartis' Lung Cancer Candidate Misses Primary Goal In Post Surgery Setting
August 15, 2022
Tickers
NVS
Tags
Biotech
Briefs
Benzinga
From
Benzinga
The Most Expensive Drug From Novartis Associated With Two Deaths: Report
August 12, 2022
Tickers
GDRX
NVS
Tags
General
Briefs
FDA
From
Benzinga
This Nasal Spray For Eye Disease Stock Is 'Attractive', Has Potential 160% Upside
August 11, 2022
Tickers
ABBV
NVS
OYST
Tags
Benzinga
OYST
Trading Ideas
From
Benzinga
Deciphera's Cancer Drug Tops Pfizer's Sutent On Safety Front In Gastrointestinal Cancer
August 11, 2022
Tickers
DCPH
NVS
PFE
Tags
General
DCPH
Biotech
From
Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
Tickers
AZN
EVO
KTTA
MRK
Tags
Tech
General
EVO
From
Benzinga
Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024
August 05, 2022
Tickers
NVS
PFE
VYGR
Tags
Biotech
VYGR
Benzinga
From
Benzinga
Here's Why Income Investors Should Consider Buying This High-Yield Dividend Stock
August 02, 2022
Tickers
NVS
Tags
NVS
Market News
^GSPC
From
Motley Fool
Death Cross Looms Over Novartis Investors
August 01, 2022
Tickers
NVS
Tags
Benzinga
Movers
Markets
From
Benzinga
Alnylam's Strategy Is Getting Bigger. Time to Buy?
July 30, 2022
Tickers
ALNY
NVO
NVS
Tags
Recent Press Releases
NVS
NVO
From
Motley Fool
Mark Cuban Says Americans Shouldn't Have To Pick Between Rent, Food Or Medicine
July 29, 2022
Tickers
NVS
PFE
Tags
Market News
Mark Cuban
NVS
From
Benzinga
This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence
July 27, 2022
Tickers
BAYRY
BRTX
NVS
Tags
Market News
NVS
Penny Stocks
From
Benzinga
7 Cathie Wood Stocks Trading at a Discount Right Now
July 26, 2022
Tickers
ARKF
ARKG
ARKK
ARKQ
Tags
Stocks to Buy
COIN
NTLA
From
InvestorPlace
As Snap Spooks Market, Here Are The Hits & Misses Of Q2 Reporting Season
July 23, 2022
Tickers
ABT
AXP
BAC
BIIB
Tags
JNJ
VZ
TSLA
From
Benzinga
New Indication Approval For Incyte "To Usher New Growth Avenue"
July 21, 2022
Tickers
INCY
LLY
NVS
Tags
Benzinga
Briefs
LLY
From
Benzinga
HC Wainwright Starts Coverage On This 'Best-In-Class Agent For Inflammatory Disorders
July 21, 2022
Tickers
MLTX
NVS
Tags
General
Briefs
why it's moving
From
Benzinga
What This FDA Delay Means for Novartis
July 21, 2022
Tickers
BGNE
BMY
MRK
NVS
Tags
Recent Press Releases
BGNE
NVS
From
Motley Fool
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today